by Hanna | Sep 4, 2024 | Blog Post
On a recent episode of the ABA Antitrust Podcast Our Curious Amalgam, Dr. Penka Kovacheva, Cornerstone Research Vice President and lead author of a paper recently published in Concurrences, “The Impact of Pharmaceutical M&A on Innovation,” discusses many ways in...
by Hanna | Aug 7, 2024 | Blog Post
A recent article from BioPharma Dive highlights the challenging landscape for biopharmaceutical initial public offerings (IPOs), and the critical role that mergers & acquisitions play in connecting promising innovations with the resources and investment needed to...
by Hanna | Jul 31, 2024 | Blog Post
In a recent article published in Concurrences Law & Economics, Cornerstone Research experts Lorenzo Cattivelli, Anca Cojoc, Penka Kovacheva and Maria Salgado highlight ways that mergers and acquisitions (M&A) can contribute to innovation in the...
by Hanna | Jul 24, 2024 | Blog Post
The U.S. House Committee on Ways and Means recently held a field hearing in Salt Lake City, UT: “Access to Health Care in America: Unleashing Medical Innovation and Economic Prosperity.” While discussing the many challenges and unique market dynamics that shape life...
by Hanna | Jul 17, 2024 | Blog Post, Innovations Advanced by M&A
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the importance of mergers and acquisitions in ensuring a competitive and vibrant biopharmaceutical landscape for patients. You can find previous blogs in this...
by Hanna | Jul 8, 2024 | Blog Post
Mergers and acquisitions (M&A) play a unique and fundamental role in the development of new treatments and cures across the pharmaceutical ecosystem. A research article published yesterday, “The impact of pharmaceutical M&A on innovation: Insights from the...
